Peer Review History
| Original SubmissionJanuary 12, 2021 |
|---|
|
PONE-D-21-01177 Affective communication with patients with limited health literacy in the palliative phase of COPD or lung cancer: analysis of video-recorded consultations in outpatient care PLOS ONE Dear Dr. Otte, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. As you will see, both reviewers found your findings interesting, but they have concerns about the (small) sample. Hence, I would ask you to pay special attention in your revision explaining the exact patient sample in more detail and be more cautious in drawing conclusions based on the presented results. I also agree that additional qualitative analyses would strengten your manuscript considerably. Please submit your revised manuscript by May 07 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Barbara Schouten Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 3. Please provide more information on the consultations with Health care providers so that others could replicate the study. For example, if an interview guide was used in the study, please include a copy as Supporting Information. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The present study describes expressions of emotional cues and concerns and the responses of physicians and nurses in a small sample of 18 consultations with COPD and lung cancer patients in palliative care. In the Introduction the authors point to the need to study the affective communication between patients with low health literacy in a palliative phased and their providers, which they describe as a gap in the literature. The aim of the study is to address this gap by investigating affective communication for the patient group. The Results section is quite straightforward and descriptive, consisting mostly of counting the numbers and concerns of patients and of clinician responses, which are described as explicit vs. non-explicit in relation to cues/concerns and in terms of whether or not they provide space for further disclose of the cue and concerns. In the Discussion, the authors make a point of the finding that while a majority of cues were clinician-elicited, concerns were more often patient-elicited. The sample is way too small draw conclusions from their data. If only three more concerns had been clinician elicited, the percentage of clinician elicited utterances had been the same as for cues. The authors suggest that cues and concerns may be more prevalent in the palliative than in a curative phase of treatment and care and also that cues and concerns could be more prevalent among patients with limited health literacy. In evaluating the number of cues and concern per consultation, the authors compare their own findings with two other studies only, which both report lower frequencies. However, the literature includes a number of other studies applying VR-CoDES which report higher frequencies of cues and concerns. Moreover, the authors do not provide a comparison between low literacy and high literacy patients. The conclusion of the authors, that “patients with limited health literacy seem to express more cues and concerns than other patient population” cannot be drawn simply based on the reported findings. To sum up, the study reports interesting descriptive data on affective communication with low literacy palliative patients, but the data set is not large enough to warrant the conclusion drawn in the Discussion section. A qualitative analysis of the data set might provide a more interesting picture of affective communication in consultations with this particular patient group. Reviewer #2: Review PNOS affecitve communication, Verona Coding General remarks: The study presents interesting data about a very specific patient population: patients with advanced lung disease, either COPD or lung cancer with low health literacy. I could imagine that it was hard work to gather the data and appreciate the author’s attempt to have a closer look at some aspects of care for this vulnerable group of patients. However, I have some major problems with the paper in its current form: I did not find a good definition of ‘palliative’ care. In this age group, the very diagnosis of COPD probably means that a curative option does not exist (lung transplantation?). In addition, lung carcinoma in general is not necessarily a palliative situation, even in this age group. Therefore, I would like to read who had assigned patients to the group of ‘palliative patients’ based upon which criteria? If ‘palliative’ is just the opposite of ‘curative’ one could assume that everybody in this age group with a chronic disease, be it coronary heart disease or chronic arthritis, is a palliative case because curative options are no longer available, etc. The authors often compare their data to data from other patient populations, but I doubt whether this is justified. If neither patients in a palliative setting, as opposed to patients in early stages of breast cancer (Lidia paper) nor patients with low health literacy have been investigated, any difference found between data in this paper and the references cannot be attributed with certainty. Yet, I think as an observational study this paper is worth publishing, but I recommend being much more conservative in drawing conclusions based upon comparison with the existing literature. In spite of my critical remarks I think these data are interesting because they show that low health literacy does not silence patients – they are still able to express their concerns (even in the form of patient-elicited concerns) and are willing and able to respond to hcp’s attempts to open space and bring in hints to negative underlying emotions. That is good news and should prompt hcp’s not to take a pessimistic stance like: “These patients don’t understand, what is going on”. Some details are listed below: Intro: Anticipating patients’ emotional responses by healthcare providers (HCPs) being empathic, reassuring and supportive is called ‘affective communication’ I’m not so sure whether ‘anticipating’ is the correct term here. The authors probably don’t assume that hcps possess the witch power to predict whether the next statement of a patient will be a concern? The very next sentence, listing characteristics of affective listening makes clear that this is not the case. Instead, the task here is not to ignore affective utterances but to respond to them with one of the quoted communication acts. Methods: ‘Patients were also included if professionals considered them to be LHL (expert opinion).’ That’s an interesting idea, however, drawing from our experience with hcp’s inability to decide correctly, whether a patient needs the help of an interpreting service, the reader might wish to know how reliable such an estimation was. Why was this included in the inclusion criteria? How often did it occur? ‘patients were excluded from participating if they 1) were in the terminal phase of their disease’ This makes me think of the definition of a palliative phase. I understand that this does not necessarily refer to the final phase of a disease, but then, palliative might refer to a disease that is rather not amenable to a curative approach. Is that the definition used? Discussion: ‘The cues and concerns of patients in the palliative phase with limited health literacy may be of a different order or more prevalent than in other patients in the curative phase.’ Besides a problem with phrasing (‘different order’?) I wonder whether this sentence is justified. We see a mixture of two factors mentioned: low versus high or average health literacy, and curative versus palliative phase of a disease. I think that these two factors cannot be disentangled within this design – there are no data on patients in a similar phase of their disease being non-low in health literacy. ‘This is relevant because the patients in this study expressed cues and concerns indicating distressing misunderstandings.’ Did I miss this point? Where do the authors present data on the nature of the cues and concerns that would indicate that they are related to misunderstandings? Is this based upon the assumption that high health literacy is effective against misunderstandings? Then, this connection should be made explicit. Basically, I am not so sure, whether this is the case. Couldn’t it be that hcps adjust their wording and the complexity of information to their perception of patients’ health literacy in such a way that ‘smarter’ patients are getting more information thereby offsetting the benefit of a higher health literacy? The very next sentence in the discussion paper would rather strengthen my skeptical comment: patients refer to their fear of suffocation and that’s not a misunderstanding but harsh reality. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Wolf Langewitz [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Affective communication with patients with limited health literacy in the palliative phase of COPD or lung cancer: analysis of video-recorded consultations in outpatient care PONE-D-21-01177R1 Dear Dr. Otte, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Barbara Schouten Academic Editor PLOS ONE Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: My comments to the first submission of this manuscript have been satisfactorily handled. No further comments. Reviewer #2: Thanks for carefully addressing the two reviewers' comments. It's reassuring to read that both had similar comments ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Wolf Langewitz |
| Formally Accepted |
|
PONE-D-21-01177R1 Affective communication with patients with limited health literacy in the palliative phase of COPD or lung cancer: analysis of video-recorded consultations in outpatient care Dear Dr. Otte: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Barbara Schouten Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .